Sirolimus for skin sarcoidosis on the face
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial tests whether sirolimus, a medicine that calms the immune system, can improve skin sarcoidosis on the face. It may help people whose skin symptoms are moderate to severe and haven't improved with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have skin sarcoidosis on your face that is moderate to severe.
- You have not had systemic treatment before, or you have tried at least one standard treatment that didn't work.
- You are not pregnant or breastfeeding, and if you can get pregnant, you agree to use effective birth control during treatment and for 12 weeks after.
- You do not have severe liver problems, high cholesterol or triglycerides, or uncontrolled high blood pressure.
- You have not used certain other immune-suppressing drugs or treatments within the past month to 3 months, depending on the drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral drug called brepocitinib to see if it can help people with skin sarcoidosis and reduce skin symptoms. It aims to find a better treatment option for this condition.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
This trial tests whether sirolimus, a medication usually used to prevent organ transplant rejection, can help reduce lupus disease activity. If you have active lupus that isn't severe in your kidneys or brain, this could be a new treatment option.
This trial studies whether hydroxychloroquine can control extrapulmonary sarcoidosis (sarcoidosis outside the lungs) using less steroid treatment. It may help people who need systemic therapy for problems such as eyes, skin, bones, joints, nerves, ENT areas, or high calcium levels from sarcoidosis.
This trial tests whether the drug sirolimus (rapamycin) can help people with dilated cardiomyopathy who also have a specific virus (KSHV) in their blood. It aims to see if sirolimus can improve heart function.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.